New 3-(hydroxybenzylidenyl)-indolin-2-ones
US5382593A · kind A · utility
38Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 1993 |
| Grant date | Jan 17, 1995 |
| Priority date | — |
| Expiry date | Jul 20, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a compound selected from those of formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and X are as defined in the description, its Z and E isomers, its optical isomers, in pure form or in the form of a mixture, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful in treating a disorder resulting from or associated with peroxidation phenomena, disturbances in eicosanoid synthesis, or with platelet aggregation disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.